Endovia Regulatory Tuesday, August 25, 2026 +0.26 Positive

Endovia Health Sciences Receives FDA Regulatory Milestone for CannEpil Veterinary Program

Endovia Health Sciences, formerly Splash Beverage, received Investigational New Animal Drug (INAD) status for its veterinary cancer pain treatment CannEpil, marking its first regulatory milestone under the Lupvindol collaboration.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day